Functional characterization of Clostridium difficile spore coat proteins

Journal of Bacteriology

Volumn 195, Issue 7, 2013, Pages 1492-1503

  Permpoonpattana, Patima ^a   Phetcharaburanin, Jutarop ^a   Mikelsone, Anna ^a   Dembek, Marcin ^b   Tan, Sisareuth ^c   Brisson, Marie Clémence ^c   La Ragione, Roberto ^d,e   Brisson, Alain R ^c   Fairweather, Neil ^b   Hong, Huynh A ^a   Cutting, Simon M ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITÉ DE BORDEAUX   (France)

^d VETERINARY LABORATORIES AGENCY   (United Kingdom)

^e UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CATALASE; CHITINASE; COTA PROTEIN; COTB PROTEIN; COTCB PROTEIN; COTD PROTEIN; COTE PROTEIN; COTF PROTEIN; COTG PROTEIN; HYDROGEN PEROXIDE; MANGANESE; PEROXIREDOXIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL GENE; BACTERIAL SPORE; BACTERIUM MUTANT; CLOSTRIDIUM DIFFICILE; CONTROLLED STUDY; DETOXIFICATION; ENZYME ACTIVITY; GENE MUTATION; MUTAGENESIS; NONHUMAN; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN PROCESSING;

BACTERIAL PROTEINS; CLOSTRIDIUM DIFFICILE; ENZYMES; GENE KNOCKOUT TECHNIQUES; MUTAGENESIS, INSERTIONAL; SPORES, BACTERIAL;

CLOSTRIDIUM DIFFICILE;

EID: 84875531755     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.02104-12     Document Type: Article

References (49)

1. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 7:526-536.
2. Gerding DN, Muto CA, Owens RC, Jr. 2008. Measures to control and prevent Clostridium difficile infection. Clin. Infect. Dis. 46(Suppl 1):S43- S49.
3. Vonberg RP, Kuijper EJ, Wilcox MH, Barbut F, Tull P, Gastmeier P, van den Broek PJ, Colville A, Coignard B, Daha T, Debast S, Duerden BI, van den Hof S, van der Kooi T, Maarleveld HJ, Nagy E, Notermans DW, O'Driscoll J, Patel B, Stone S, Wiuff C. 2008. Infection control measures to limit the spread of Clostridium difficile. Clin. Microbiol. Infect. 14(Suppl 5):2-20.
4. Lawley TD, Clare S, Walker AW, Goulding D, Stabler RA, Croucher N, Mastroeni P, Scott P, Raisen C, Mottram L, Fairweather NF, Wren BW, Parkhill J, Dougan G. 2009. Antibiotic treatment of Clostridium difficile carrier mice triggers a supershedder state, spore-mediated transmission, and severe disease in immunocompromised hosts. Infect. Immun. 77: 3661-3669.
5. Eggertson L, Sibbald B. 2004. Hospitals battling outbreaks of C. difficile. CMAJ 171:19-21.
6. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, Michaud S, Bourgault AM, Nguyen T, Frenette C, Kelly M, Vibien A, Brassard P, Fenn S, Dewar K, Hudson TJ, Horn R, Rene P, Monczak Y, Dascal A. 2005. A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353:2442-2449.
7. McDonald LC, Killgore GE, Thompson A, Owens RC, Jr, Kazakova SV,Sambol SP, Johnson S, Gerding DN. 2005. An epidemic, toxin genevariant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-2441.
8. Merrigan M, Venugopal A, Mallozzi M, Roxas B, Viswanathan VK, Johnson S, Gerding DN, Vedantam G. 2010. Human hypervirulent Clostridium difficile strains exhibit increased sporulation as well as robust toxin production. J. Bacteriol. 192:4904-4911.
9. Kuijper EJ, van Dissel JT, Wilcox MH. 2007. Clostridium difficile: changing epidemiology and new treatment options. Curr. Opin. Infect. Dis. 20:376-383.
10. Vohra P, Poxton IR. 2011. Comparison of toxin and spore production in clinically relevant strains of Clostridium difficile. Microbiology 157:1343- 1353.
11. Burns DA, Heeg D, Cartman ST, Minton NP. 2011. Reconsidering the sporulation characteristics of hypervirulent Clostridium difficile BI/NAP1/ 027. PLoS One 6:e24894. doi:10.1371/journal.pone.0024894.
12. Lawley TD, Croucher NJ, Yu L, Clare S, Sebaihia M, Goulding D, Pickard DJ, Parkhill J, Choudhary J, Dougan G. 2009. Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores. J. Bacteriol. 191:5377-5386.
13. Haraldsen JD, Sonenshein AL. 2003. Efficient sporulation in Clostridium difficile requires disruption of the sigmaK gene. Mol. Microbiol. 48:811- 821.
14. Cutting S, Oke V, Driks A, Losick R, Lu S, Kroos L. 1990. A forespore checkpoint for mother cell gene expression during development in B. subtilis. Cell 62:239-250.
15. Paredes CJ, Alsaker KV, Papoutsakis ET. 2005. A comparative genomic view of clostridial sporulation and physiology. Nat. Rev. Microbiol. 3:969-978.
16. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, Stabler R, Thomson NR, Roberts AP, Cerdeno-Tarraga AM, Wang H, Holden MT, Wright A, Churcher C, Quail MA, Baker S, Bason N, Brooks K, Chillingworth T, Cronin A, Davis P, Dowd L, Fraser A, Feltwell T, Hance Z, Holroyd S, Jagels K, Moule S, Mungall K, Price C, Rabbinowitsch E, Sharp S, Simmonds M, Stevens K, Unwin L, Whithead S, Dupuy B, Dougan G, Barrell B, Parkhill J. 2006. The multidrug-resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-786.
17. Henriques AO, Moran CP, Jr. 2007. Structure, assembly, and function of the spore surface layers. Annu. Rev. Microbiol. 61:555-588.
18. Permpoonpattana P, Tolls EH, Nadem R, Tan S, Brisson A, Cutting SM. 2011. Surface layers of Clostridium difficile endospores. J. Bacteriol. 193:6461- 6470.
19. Hussain HA, Roberts AP, Mullany P. 2005. Generation of an erythromycin- sensitive derivative of Clostridium difficile strain 630 (630Derm) and demonstration that the conjugative transposon Tn916DE enters the genome of this strain at multiple sites. J. Med. Microbiol. 54:137-141.
20. Wust J, Sullivan NM, Hardegger U, Wilkins TD. 1982. Investigation of an outbreak of antibiotic-associated colitis by various typing methods. J. Clin. Microbiol. 16:1096-1101.
21. Paredes-Sabja D, Bond C, Carman RJ, Setlow P, Sarker MR. 2008. Germination of spores of Clostridium difficile strains, including isolates from a hospital outbreak of Clostridium difficile-associated disease (CDAD). Microbiology 154:2241-2250.
22. Permpoonpattana P, Hong HA, Phetcharaburanin J, Huang JM, Cook J, Fairweather NF, Cutting SM. 2011. Immunization with Bacillus spores expressing toxin A peptide repeats protects against infection with Clostridium difficile strains producing toxins A and B. Infect. Immun. 79:2295- 2302.
23. Heap JT, Pennington OJ, Cartman ST, Carter GP, Minton NP. 2007. The ClosTron: a universal gene knock-out system for the genus Clostridium. J. Microbiol. Methods 70:452- 464.
24. Heap JT, Pennington OJ, Cartman ST, Minton NP. 2009. A modular system for Clostridium shuttle plasmids. J. Microbiol. Methods 78:79-85.
25. Heap JT, Kuehne SA, Ehsaan M, Cartman ST, Cooksley CM, Scott JC, Minton NP. 2010. The ClosTron: mutagenesis in Clostridium refined and streamlined. J. Microbiol. Methods 80:49-55.
26. Perutka J, Wang W, Goerlitz D, Lambowitz AM. 2004. Use of computerdesigned group II introns to disrupt Escherichia coli DExH/D-box protein and DNA helicase genes. J. Mol. Biol. 336:421- 439.
27. Antunes A, Martin-Verstraete I, Dupuy B. 2011. CcpA-mediated repression of Clostridium difficile toxin gene expression. Mol. Microbiol. 79:882- 899.
28. Fagan RP, Fairweather NF. 2011. Clostridium difficile has two parallel and essential Sec secretion systems. J. Biol. Chem. 286:27483-27493.
29. Hong HA, Khaneja R, Tam NM, Cazzato A, Tan S, Urdaci M, Brisson A, Gasbarrini A, Barnes I, Cutting SM. 2009. Bacillus subtilis isolated from the human gastrointestinal tract. Res. Microbiol. 160:134-143.
30. Marklund S, Marklund G. 1974. Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase. Eur. J. Biochem. 47:469-474.
31. Attar F, Keyhani E, Keyhani J. 2006. A comparative study of superoxide dismutase activity assays in Crocus sativus L. Corm. Appl. Biochem. Microbiol. 42:101-106.
32. Greetham D, Grant CM. 2009. Antioxidant activity of the yeast mitochondrial one-Cys peroxiredoxin is dependent on thioredoxin reductase and glutathione in vivo. Mol. Cell. Biol. 29:3229-3240.
33. Logan C, Mayhew SG. 2000. Cloning, overexpression, and characterization of peroxiredoxin and NADH peroxiredoxin reductase from Thermus aquaticus. J. Biol. Chem. 275:30019-30028.
34. Mizobata T, Kagawa M, Murakoshi N, Kusaka E, Kameo K, Kawata Y, Nagai J. 2000. Overproduction of Thermus sp. YS 8-13 manganese catalase in Escherichia coli production of soluble apoenzyme and in vitro formation of active holoenzyme. Eur. J. Biochem. 267:4264-4271.
35. Sekiya M, Mulcahy G, Irwin JA, Stack CM, Donnelly SM, Xu W, Collins P, Dalton JP. 2006. Biochemical characterisation of the recombinant peroxiredoxin (FhePrx) of the liver fluke, Fasciola hepatica. FEBS Lett. 580:5016-5022.
36. Duc LH, Hong HA, Fairweather N, Ricca E, Cutting SM. 2003. Bacterial spores as vaccine vehicles. Infect. Immun. 71:2810-2818.
37. Duc LH, Hong HA, Uyen NQ, Cutting SM. 2004. Intracellular fate and immunogenicity of B. subtilis spores. Vaccine 22:1873-1885.
38. Lawley TD, Clare S, Deakin LJ, Goulding D, Yen JL, Raisen C, Brandt C, Lovell J, Cooke F, Clark TG, Dougan G. 2010. Use of purified Clostridium difficile spores to facilitate evaluation of health care disinfection regimens. Appl. Environ. Microbiol. 76:6895- 6900.
39. Wei J, Shah IM, Ghosh S, Dworkin J, Hoover DG, Setlow P. 2010. Superdormant spores of Bacillus species germinate normally with high pressure, peptidoglycan fragments, and bryostatin. J. Bacteriol. 192:1455- 1458.
40. Panessa-Warren BJ, Tortora GT, Warren JB. 1997. Exosporial membrane plasticity of Clostridium sporogenes and Clostridium difficile. Tissue Cell 29:449-461.
41. Henrissat B, Davies GJ. 2000. Glycoside hydrolases and glycosyltransferases. Families, modules, and implications for genomics. Plant Physiol. 124:1515-1519.
42. Rao FV, Andersen OA, Vora KA, Demartino JA, van Aalten DM. 2005. Methylxanthine drugs are chitinase inhibitors: investigation of inhibition and binding modes. Chem. Biol. 12:973-980.
43. Zheng L, Donovan WP, Fitz-James PC, Losick R. 1988. Gene encoding a morphogenic protein required in the assembly of the outer coat of the Bacillus subtilis endospore. Genes Dev. 2:1047-1054.
44. Kim H, Hahn M, Grabowski P, McPherson DC, Otte MM, Wang R, Ferguson CC, Eichenberger P, Driks A. 2006. The Bacillus subtilis spore coat protein interaction network. Mol. Microbiol. 59:487-502.
45. Isticato R, Esposito G, Zilhao R, Nolasco S, Cangiano G, De Felice M, Henriques AO, Ricca E. 2004. Assembly of multiple CotC forms into the Bacillus subtilis spore coat. J. Bacteriol. 186:1129-1135.
46. Piggot PJ, Coote JG. 1976. Genetic aspects of bacterial endospore formation. Bacteriol. Rev. 40:908-962.
47. Tanaka T, Fujiwara S, Nishikori S, Fukui T, Takagi M, Imanaka T. 1999. A unique chitinase with dual active sites and triple substrate binding sites from the hyperthermophilic archaeon Pyrococcus kodakaraensis KOD1. Appl. Environ. Microbiol. 65:5338-5344.
48. Henriques AO, Melsen LR, Moran CP, Jr. 1998. Involvement of superoxide dismutase in spore coat assembly in Bacillus subtilis. J. Bacteriol. 180:2285-2291.
49. Henriques AO, Moran CP. 2000. Structure and assembly of the bacterial endospore coat. Methods 20:95-110.